Mediantechn Market Cap ($157.26 Million)
Market Cap & Net Worth: Mediantechn (ALMDT)
Mediantechn market cap. Mediantechn (PA:ALMDT) has a market capitalization of $157.26 Million (€134.51 Million) as of November 4, 2026. Listed on the PA stock exchange, this France-based company holds position #17297 globally and #248 in its home market, demonstrating a -12.62% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Mediantechn's stock price €3.53 by its total outstanding shares 38105068 (38.11 Million). Also see Mediantechn cash flow conversion for how efficiently the company converts equity into cash flow.
Mediantechn Market Cap History (2015–2026)
Mediantechn market cap history from 2015 to 2026. Data shows change from $534.59 Million to $157.26 Million (-10.48% CAGR). Check Mediantechn stock price for real-time trading data and today's change.
Mediantechn Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Mediantechn's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore ALMDT year-over-year net asset growth to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
9.03x
Mediantechn's market cap is 9.03 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $490.04 Million | $6.35 Million | -$9.11 Million | 77.12x | N/A |
| 2017 | $400.94 Million | $7.69 Million | -$17.21 Million | 52.16x | N/A |
| 2018 | $44.01 Million | $6.34 Million | -$15.28 Million | 6.94x | N/A |
| 2019 | $87.76 Million | $8.95 Million | -$7.99 Million | 9.80x | N/A |
| 2020 | $307.39 Million | $13.48 Million | -$12.80 Million | 22.81x | N/A |
| 2021 | $696.74 Million | $20.55 Million | -$19.29 Million | 33.91x | N/A |
| 2022 | $396.04 Million | $23.67 Million | -$20.21 Million | 16.73x | N/A |
| 2023 | $211.61 Million | $22.23 Million | -$22.98 Million | 9.52x | N/A |
| 2024 | $168.17 Million | $22.95 Million | -$25.24 Million | 7.33x | N/A |
| 2025 | $210.94 Million | $23.36 Million | -$34.07 Million | 9.03x | N/A |
Competitor Companies of ALMDT by Market Capitalization
Companies near Mediantechn in the global market cap rankings as of November 4, 2026. Also see ALMDT total asset value for a full breakdown of the balance sheet.
Key companies related to Mediantechn by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #110 globally with a market cap of $191.55 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #204 globally with a market cap of $117.68 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #227 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #240 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #110 | Abbott Laboratories | NYSE:ABT | $191.55 Billion | $110.16 |
| #204 | Stryker Corporation | NYSE:SYK | $117.68 Billion | $306.81 |
| #227 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $99.29 |
| #240 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Market Capitalization of Mediantechn (2015–2026)
Market capitalization of Mediantechn from 2015 to today. Between 2015 and today, Mediantechn's market cap moved from $534.59 Million to $ 157.26 Million, with a yearly change of -10.48%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €157.26 Million | -25.45% |
| 2025 | €210.94 Million | +25.43% |
| 2024 | €168.17 Million | -20.53% |
| 2023 | €211.61 Million | -46.57% |
| 2022 | €396.04 Million | -43.16% |
| 2021 | €696.74 Million | +126.67% |
| 2020 | €307.39 Million | +250.25% |
| 2019 | €87.76 Million | +99.39% |
| 2018 | €44.01 Million | -89.02% |
| 2017 | €400.94 Million | -18.18% |
| 2016 | €490.04 Million | -8.33% |
| 2015 | €534.59 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 3rd, 2026 the market cap of Mediantechn was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $157.26 Million USD |
| MoneyControl | $157.26 Million USD |
| MarketWatch | $157.26 Million USD |
| marketcap.company | $157.26 Million USD |
| Reuters | $157.26 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Mediantechn
Median Technologies SA engages in providing medical imaging products and services for diagnosing and monitoring cancer patients in both routine clinical practice and clinical drug development with operations spanning in France, the United States, Canada, the United Kingdom, China, and internationally. The company offers iSee for imaging services in clinical trials; eyonis for non-invasive diagnos… Read more